City of Hope's Pathology Repository, also known as the biospecimen or solid tumor biorepository, serves as a mechanism for the procurement, processing, management, storage and distribution of fresh and banked human biological materials from patients seen at City of Hope Medical Center (“City of Hope”) and affiliated institutions. These patients have been diagnosed or are suspected of having solid tumor malignancies, including lymphoma. Investigators who wish to obtain tissue for research must submit a Letter of Intent (“LOI”) in accordance with their study application in iRIS. All proposals for research using freshly procured and banked human biological materials will be reviewed and approved by the appropriate Disease Team, the IRB, CPMRC and the core committee.
Karen Miller, CLS, MT (ASCP)
Senior Manager
The biorepository services include patient consenting to City of Hope’s general research protocol. With consent in place, biospecimens are ethically procured under the supervision of pathologists, processed, stored, and fully annotated following ISBER's Best Practices and National Cancer Institute's Best Practices for Biospecimen Resources. If you receive care at City of Hope, please understand that we may approach you for permission to use your specimens and medical information about your condition for research. Of course, you are always free to decline.
Current pricing can be found on iLab Solutions.
In a given year, City of Hope conducts more than 400 clinical trials enrolling more than 6,000 patients.
City of Hope is focused on basic and clinical research in cancer, diabetes and other life-threatening diseases.
